Your browser is no longer supported. Please, upgrade your browser.
Settings
BMY Bristol-Myers Squibb Company daily Stock Chart
BMY [NYSE]
Bristol-Myers Squibb Company
IndexS&P 500 P/E19.33 EPS (ttm)3.46 Insider Own0.10% Shs Outstand2.34B Perf Week0.44%
Market Cap156.29B Forward P/E10.70 EPS next Y6.25 Insider Trans-1.32% Shs Float2.34B Perf Month5.29%
Income5.66B PEG1.28 EPS next Q0.91 Inst Own60.30% Short Float2.91% Perf Quarter22.88%
Sales24.17B P/S6.47 EPS this Y28.70% Inst Trans0.63% Short Ratio3.64 Perf Half Y54.68%
Book/sh10.81 P/B6.19 EPS next Y42.68% ROA12.40% Target Price70.60 Perf Year33.85%
Cash/sh13.92 P/C4.80 EPS next 5Y15.05% ROE35.90% 52W Range42.48 - 68.34 Perf YTD4.18%
Dividend1.80 P/FCF31.77 EPS past 5Y14.50% ROI25.40% 52W High-2.15% Beta0.74
Dividend %2.69% Quick Ratio3.70 Sales past 5Y6.60% Gross Margin70.80% 52W Low57.42% ATR0.99
Employees23300 Current Ratio3.80 Sales Q/Q5.60% Oper. Margin35.00% RSI (14)70.53 Volatility1.32% 1.37%
OptionableYes Debt/Eq1.41 EPS Q/Q-29.50% Profit Margin23.40% Rel Volume0.71 Prev Close67.43
ShortableYes LT Debt/Eq1.38 EarningsFeb 06 BMO Payout47.10% Avg Volume18.66M Price66.87
Recom1.90 SMA203.08% SMA508.44% SMA20029.99% Volume13,170,534 Change-0.83%
Jan-06-20Resumed Citigroup Buy $73
Dec-13-19Upgrade Argus Hold → Buy $80
Nov-22-19Resumed Morgan Stanley Equal-Weight $60
Oct-17-19Resumed BofA/Merrill Buy $60
Aug-14-19Upgrade Atlantic Equities Neutral → Overweight $63
May-28-19Initiated Goldman Buy
May-20-19Downgrade Argus Buy → Hold
May-03-19Upgrade Barclays Equal Weight → Overweight $53 → $55
May-03-19Resumed JP Morgan Overweight $62
Jan-15-19Upgrade Societe Generale Sell → Buy
Oct-22-18Downgrade Citigroup Buy → Neutral
Oct-09-18Resumed Guggenheim Neutral
Aug-08-18Upgrade Atlantic Equities Underweight → Neutral
Apr-17-18Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-12-18Reiterated Citigroup Buy $78 → $70
Mar-20-18Reiterated JP Morgan Overweight $70 → $75
Feb-15-18Upgrade Morgan Stanley Equal-Weight → Overweight
Oct-30-17Upgrade SunTrust Hold → Buy
Oct-16-17Downgrade Jefferies Buy → Hold
Sep-12-17Downgrade Hilliard Lyons Long-term Buy → Neutral
Jan-23-20 06:00PM  Gilead, Bristol-Myers Pumped More Into R&D Than Shareholder Enrichments GuruFocus.com
12:45PM  Index Fund Giants Draw Antitrust Scrutiny in U.S. Mergers Bloomberg
10:39AM  Amgen Stock Is Poised to Gain in 2020, Analyst Says. Heres Why. Barrons.com
Jan-22-20 05:45PM  Bristol-Myers Squibb (BMY) Flat As Market Gains: What You Should Know Zacks
10:03AM  Horizon Therapeutics Gets FDA Approval for Eye Drug Tepezza Zacks
09:28AM  The Extreme Risks of Trading Your Own Retirement Assets - January 22, 2020 Zacks
09:16AM  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now? Zacks
07:04AM  5 Stocks Near a 52-Week High That Can Scale Higher Zacks
Jan-21-20 09:22AM  Top Ranked Momentum Stocks to Buy for January 21st Zacks
Jan-20-20 11:50AM  Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock? Zacks
11:40AM  BMY or AZN: Which Is the Better Value Stock Right Now? Zacks
Jan-17-20 02:47PM  9 Takeaways From The JPMorgan Healthcare Conference Benzinga
09:35AM  Is Bristol-Myers Squibb (BMY) a Good Stock to Pick Now? Zacks
08:11AM  Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates Zacks
05:00AM  Top Picks 2020- Bristol-Myers Squibb BMY MoneyShow
Jan-16-20 09:01AM  J&J Seeks Label Expansion for Spravato Nasal Spray in EU Zacks
08:54AM  Zacks.com featured highlights include: Genesco, GreenTree Hospitality, Bristol-Myers Squibb, Barclays PLC and Valero Energy Zacks
08:52AM  Bristol-Myers' Opdivo-Yervoy sBLA for NSCLC Accepted by FDA Zacks
07:22AM  The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics Benzinga
Jan-15-20 10:27AM  Nektar's Pain Drug Gets Adverse Advisory Committee Decision Zacks
10:01AM  Snap Up These 5 Stocks With High Earnings Yield Zacks
08:37AM  Top Ranked Income Stocks to Buy for January 15th Zacks
08:00AM  3 Large-Cap Dividend Stocks to Buy Now for Your 2020 Portfolio Zacks
06:59AM  U.S. Food and Drug Administration Accepts for Priority Review Bristol-Myers Squibbs Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) in First-Line Non-Small Cell Lung Cancer Business Wire
Jan-14-20 01:02PM  Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc. Moody's
11:13AM  Big Merger Deals Are Missing at Health Conference. Heres Why. Barrons.com
08:01AM  Top Ranked Income Stocks to Buy for January 14th Zacks
Jan-13-20 05:45PM  Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know Zacks
09:46AM  In time for biotech's biggest conference, Union Square costs climb American City Business Journals
09:38AM  The Extreme Risks of Trading Your Own Retirement Assets - January 13, 2020 Zacks
09:34AM  Retirees Should Know These 3 Facts About Required Minimum Distributions - January 13, 2020 Zacks
09:14AM  Nektar Up 25% as Bristol-Myers Expands Bempeg Collaboration Zacks
07:58AM  Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Zacks
Jan-10-20 04:08PM  Why Bristol's Vote Of Confidence Sent This Biotech Stock Rocketing Investor's Business Daily
10:21AM  The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS Zacks
08:01AM  Nektar Therapeutics, Bristol-Myers Expand Effort to Develop Treatment for Cancer TheStreet.com
06:59AM  Nektar Therapeutics and Bristol-Myers Squibb Amend Strategic Collaboration Agreement for bempegaldesleukin Plus Opdivo (nivolumab) Business Wire
06:52AM  Bristol-Myers Squibb's Stock Could Soar to New All-Time Highs This Quarter TheStreet.com
Jan-09-20 02:43PM  Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb Zacks
09:28AM  Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar? Zacks
09:20AM  4 Things to Pay Attention to at the J.P. Morgan Health-Care Conference Next Week Barrons.com
08:00AM  Red-Hot Biotech Stocks Brace For Key Meeting Here's What To Expect Investor's Business Daily
06:59AM  New England Journal of Medicine Publishes Results of Pivotal Phase 3 Reblozyl® (luspatercept-aamt) MEDALIST Trial Business Wire
Jan-08-20 05:53PM  Among Top 5 Pharma Companies, Pfizer Was the Worst Performer in 2019 GuruFocus.com
12:45PM  3 Reasons Growth Investors Will Love Bristol-Myers (BMY) Zacks
11:19AM  Zacks.com featured highlights include: Helen of Troy, Penn National Gaming, Arcos Dorados, Insight Enterprises and Bristol-Myers Squibb Zacks
10:09AM  Easy Investing Secrets to an Early Retirement - January 08, 2020 Zacks
Jan-07-20 01:31PM  Fred Hutch taps Bristol-Myers Squibb exec as its next president American City Business Journals
12:10PM  Can Bristol-Myers (BMY) Keep the Earnings Surprise Streak Alive? Zacks
10:06AM  Urbem's 'Quality Strategy' Series: The Installed Base GuruFocus.com
09:42AM  Pfizer/Merck KGaA's Bavencio Positive in Bladder Cancer Study Zacks
09:17AM  Its Time to Buy Bristol-Myers Stock, According to 1 Analyst. Heres Why. Barrons.com
08:11AM  5 High-Flying Stocks Near 52-Week High That Can Scale Higher Zacks
03:00AM  Bristol-Myers Squibb Completes Divestment of Manufacturing Facility in Anagni, Italy Business Wire
Jan-06-20 05:45PM  Bristol-Myers Squibb (BMY) Gains But Lags Market: What You Should Know Zacks
04:16PM  Bristol-Myers Squibb to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
10:40AM  10 Stocks With the Highest Profit Growth in 2020 According to Goldman Investopedia
10:00AM  Bristol-Myers Has Now Acquired Celgene So, Should You Buy BMY Stock? Investor's Business Daily
09:45AM  Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101 Zacks
09:44AM  AstraZeneca's Farxiga sNDA Gets Priority Review Status by FDA Zacks
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
08:25AM  Leap Therapeutics Surges on License Agreement With BieGene Zacks
07:17AM  10 Stocks With the Highest Sales Growth in 2020 According to Goldman Investopedia
Jan-05-20 04:52PM  The Sectors We Try to Avoid and Why GuruFocus.com
Jan-03-20 12:00PM  Are You Looking for a Top Momentum Pick? Why Bristol-Myers Squibb (BMY) is a Great Choice Zacks
11:50AM  Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock? Zacks
11:40AM  BMY or AZN: Which Is the Better Value Stock Right Now? Zacks
09:24AM  How Trading Your Own Retirement Can Fleece Your Financial Future - January 03, 2020 Zacks
Jan-02-20 09:49AM  Top Ranked Momentum Stocks to Buy for January 2nd Zacks
09:37AM  3 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2020 Zacks
08:41AM  Bristol-Myers, Gilead, Biogen, Other Drugmakers Increased U.S. List Prices on Jan. 1: Report TheStreet.com
06:59AM  Bristol-Myers Squibb to Take Part at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference Business Wire
Jan-01-20 11:47AM  More drugmakers hike U.S. prices as new year begins Reuters
11:20AM  More drugmakers hike U.S. prices as new year begins Reuters
Dec-31-19 05:45PM  Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know Zacks
11:55AM  Beryl Capital Managements Top Stock Picks Insider Monkey
10:34AM  Beware This Pharma Stock Next Month Schaeffer's Investment Research
09:22AM  Easy Investing Secrets to an Early Retirement - December 31, 2019 Zacks
08:45AM  3 Biotech Stocks Likely to Maintain Solid Momentum in 2020 Zacks
02:59AM  Best Dividend Stocks for January 2020 Investopedia
Dec-30-19 05:17PM  BeiGene Gets Approval for Lymphoma Drug Tislelizumab in China Zacks
02:08PM  Urbem's 'Wonderful Business' Series: Waters GuruFocus.com
12:02PM  What Does Bristol-Myers Squibb Company's (NYSE:BMY) P/E Ratio Tell You? Simply Wall St.
10:35AM  An Unusual Investment With 125% Upside GuruFocus.com
10:04AM  Top Ranked Momentum Stocks to Buy for December 30th Zacks
09:36AM  Why Bristol-Myers (BMY) Stock Might be a Great Pick Zacks
09:35AM  Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now? Zacks
Dec-27-19 04:20PM  How Did Bristol Myers Squibb Company (BMY) Compare Against Hedge Fund Darlings in 2019? Insider Monkey
02:26PM  Longtime biotech exec walks away from board to concentrate on startup American City Business Journals
09:04AM  Spring Bank (SBPH) Stops Dosing in HBV Studies, Stock Down Zacks
05:30AM  The Biotech Sector Is Roaring Into 2020. Heres Why. Barrons.com
Dec-26-19 10:15AM  Top Ranked Momentum Stocks to Buy for December 26th Zacks
06:00AM  Fewer Companies Merged in 2019. Just Dont Call It a Bad Year. Barrons.com
05:15AM  Bristol-Myers Squibb May Trade Sideways for a Bit but Expect New Highs Later TheStreet.com
Dec-24-19 09:49AM  Mylan, Micro Labs receive FDA approval to market generic Eliquis MarketWatch
09:33AM  How Trading Your Own Retirement Can Fleece Your Financial Future - December 24, 2019 Zacks
07:00AM  Heres to Your Health: A Decade of Drug Breakthroughs Bloomberg
Dec-23-19 04:12PM  Pharma M&A Deals Likely To Be Smaller in 2020 GuruFocus.com
02:57PM  A Perspective On Biopharma's Record M&A Run In 2019 Benzinga
12:45PM  Here is Why Growth Investors Should Buy Bristol-Myers (BMY) Now Zacks
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers drugs in oncology, immunoscience, cardiovascular, and fibrotic diseases. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, the company offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV) and Evotaz; Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. Bristol-Myers Squibb Company has collaboration agreements with Nektar Therapeutics; Janssen Pharmaceuticals, Inc.; Biocartis Group NV.; FameWave Ltd.; Novartis; Presage Biosciences; and WindMIL Therapeutics, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Elkins David VEVP, Chief Financial OfficerDec 31Option Exercise0.0012,373026,281Jan 03 07:00 PM
VESSEY RUPERTPres., Research & Early Dev.Dec 31Option Exercise0.0016,060030,778Jan 03 07:00 PM
Dubow AdamChief Compliance & Ethics OffiDec 05Sale58.811,740102,32915,749Dec 09 04:44 PM
Eid JosephSVPHead Global Medical AffairsDec 01Option Exercise0.002,82504,995Dec 03 05:28 PM
Schmukler Louis SPres., Global Mfg. & SupplyNov 05Sale56.5625,0001,414,00031,963Nov 06 04:54 PM
Elicker John ESVP, Public Affairs & IRNov 05Sale56.6615,000849,90074,471Nov 06 04:54 PM
Biondi PaulSVP, Head of Strategy & BDOct 02Option Exercise0.0059206,417Oct 03 04:46 PM
Santiago Karen MurphyControllerSep 01Option Exercise0.0064103,707Sep 04 05:17 PM
BERTOLINI ROBERT JDirectorJul 31Buy44.7211,000491,92011,397Aug 01 05:06 PM
Samuels Theodore R. IIDirectorMay 16Buy47.295,000236,44027,000May 20 04:36 PM
Santiago Karen MurphyControllerMay 16Sale47.563,065145,7713,066May 20 04:37 PM
Caforio GiovanniChairman and CEOMay 05Option Exercise0.008,0400373,239May 06 04:40 PM
Lynch Thomas J. Jr.EVP & Chief Scientific OfficerApr 03Option Exercise0.0011,594025,816Apr 05 04:32 PM
Elicker John ESVP, Public Affairs & IRMar 10Option Exercise0.0014,180092,626Mar 13 07:42 AM
BOERNER CHRISTOPHER S.EVP, Chief Commercial OfficerMar 10Option Exercise0.0015,707014,501Mar 13 07:41 AM
Dubow AdamChief Compliance & Ethics OffiMar 10Option Exercise0.003,735018,240Mar 13 07:41 AM
Caforio GiovanniChairman and CEOMar 10Option Exercise0.00173,4190422,683Mar 13 07:40 AM
Bancroft Charles AEVP & Chief Financial OfficerMar 10Option Exercise0.0062,2550411,547Mar 13 07:39 AM
Biondi PaulSVP, Head of Strategy & BDMar 10Option Exercise0.008,61907,860Mar 13 07:39 AM
von Autenried PaulSVP, Enterp. Services & CIOMar 10Option Exercise0.0019,9250141,077Mar 13 07:38 AM
Schmukler Louis SPres., Global Mfg. & SupplyMar 10Option Exercise0.0026,568063,652Mar 13 07:37 AM
Lynch Thomas J. Jr.EVP & Chief Scientific OfficerMar 10Option Exercise0.005,864021,343Mar 13 07:36 AM
Santiago Karen MurphyControllerMar 10Option Exercise0.003,82506,850Mar 13 07:37 AM
LEUNG SANDRAEVP, General CounselMar 10Option Exercise0.0045,1700558,854Mar 13 07:35 AM
JUDGE ANN POWELLSVP, Global Human ResourcesMar 10Option Exercise0.0025,577081,508Mar 13 07:34 AM
Bancroft Charles AEVP & Chief Financial OfficerFeb 28Option Exercise17.5152,884925,999392,690Mar 04 04:42 PM
LEUNG SANDRAEVP, General CounselFeb 28Option Exercise17.51169,8932,974,826634,478Mar 04 04:42 PM
BOERNER CHRISTOPHER S.EVP, Chief Commercial OfficerFeb 02Option Exercise0.004,46504,465Feb 05 04:53 PM